logo    Company Page

Most Recent Insiders Activity

Transaction Date Company Name Insider Name (Title) Activity Stock Acquired or Disposed Shares Price range Amount
2024-03-01 Poseida Therapeutics, Inc. Gergen Mark J
(Executive Chairman)
F Common Stock D 34157 $4.13 - $4.13 $141,068
2024-03-01 Poseida Therapeutics, Inc. LEONHARDT HARRY J
(GC & Chief Compliance Officer)
F Common Stock D 16306 $4.13 - $4.13 $67,343
2024-03-01 Poseida Therapeutics, Inc. LEONHARDT HARRY J
(GC & Chief Compliance Officer)
A Common Stock A 80743 $0.00 - $0.00 $0
2024-03-01 Poseida Therapeutics, Inc. Warner Brent
(President, Gene Therapy)
F Common Stock D 35739 $4.13 - $4.13 $147,602
2024-03-01 Poseida Therapeutics, Inc. Warner Brent
(President, Gene Therapy)
A Common Stock A 80743 $0.00 - $0.00 $0
2024-02-01 Poseida Therapeutics, Inc. Gergen Mark J
(Executive Chairman)
F Common Stock D 47162 $3.41 - $3.41 $160,822
2024-01-02 Poseida Therapeutics, Inc. Yarema Kristin
(President and CEO)
A Common Stock A 250000 $0.00 - $0.00 $0
logo   

Please upgrade to premium to see all results. Signup if you don't have an account.

Login Signup
Activity types
A Grant, award or other acquisition
C Conversion of Derivative or Security
D Disposition to the issuer of issuer equity securities
E Expiration of short derivative position
F Payment of exercise price or tax liability
G Bona fide Gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary Transaction
J Other acquisition or disposition
K Transaction in equity swap or instrument with similar characteristics
L Small Acquisition
M Exercise or conversion of derivative security
O Exercise of out-of-the-money derivative security
P Open Market Purchase
S Open Market Sale
U Disposition pursuant to a tender of shares in a change of control transaction
V Transaction Voluntarily Reported
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust
Debug Info- Version: 2.6